(Newser) -
Avastin is one of the most widely prescribed cancer drugs in the world, but it might not work, the New York Times reports. The drug, made by Genentech, brings in about $2.3 billion a year in the US alone, but recent trials have shown that though the drug shrinks tumors in sufferers of colon, breast, and lung cancer, it offers little extension of life.
More »